Skip to main content
Clinical Trials/KCT0006526
KCT0006526
Completed
未知

Optimizing the dose of intrathecal morphine in patients undergoing laparoscopic donor hepatectomy; a randomized non-inferiority trial

Samsung Medical Center0 sites56 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Samsung Medical Center
Enrollment
56
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 31, 2022
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who undergo living donor hepatectomy for liver transplantation
  • ASA physical status I or II

Exclusion Criteria

  • ASA physical status III or more
  • Severe impaired coagulation profile (equal or more than INR 1\.5 last coagulation test before the surgery)
  • Patients who have unstable coronary disease or Congestive heart failure or Arrhythmia or cardiomyopathy
  • Patients who have cerebrovascular disease
  • Patients who have systemic infection or local infection on lumbar
  • Chronic pain patients
  • Patients who don't understand about study or refuse the study
  • Patients who have history of severe psychological disease

Outcomes

Primary Outcomes

Not specified

Similar Trials